Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026

Core Viewpoint - Aethlon Medical, Inc. is set to present at the Emerging Growth Conference on February 25, 2026, highlighting its focus on developing medical products for cancer and life-threatening infectious diseases [1] Company Overview - Aethlon Medical, Inc. is a clinical-stage medical device company based in San Diego, California, specializing in the development of the Hemopurifier, which targets pathogenic substances in biological fluids [1] - The Hemopurifier is designed to remove enveloped viruses and tumor-derived extracellular vesicles (EVs) from circulation, addressing unmet needs in oncology and infectious diseases [1] Product Details - The Hemopurifier has received U.S. Food and Drug Administration Breakthrough Device Designation for treating advanced or metastatic cancer unresponsive to standard therapies and for addressing life-threatening viruses [1] - The device operates extracorporeally with a blood pump, utilizing plasma separation, size exclusion, and affinity binding to target mannose-rich surfaces on EVs and viruses [1] Conference Information - The Emerging Growth Conference provides a platform for public companies to present their innovations and engage with investors, featuring a live interactive format [1] - Aethlon's CEO and CFO will participate in a fireside chat and answer questions from attendees, with an archived webcast available for those unable to attend live [1]